Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review

Denaro, Nerina and Garrone, Ornella and Occelli, Marcella and Fea, Elena and Granetto, Cristina and Merlano, Marco Carlo and Numico, Gianmauro (2021) Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review. European Journal of Case Reports in Internal Medicine, 8 (6). pp. 1-5. ISSN ISSN: 2284-2594

[img]
Preview
Text
2639-Article Text-23195-1-10-20210616.pdf - Published Version

Download (638kB) | Preview
Official URL: https://www.ejcrim.com/index.php/EJCRIM/issue/view...

Abstract

Hepatic dysfunction, in the absence of liver metastases, occurs in 10–15% of renal cell carcinoma (RCC) patients, while immune hepatitis due to anti-CTLA4 and anti-PD1 administration affects about 3–9% and 0.7–1.8% of treated patients, respectively. Liver toxicity following combination therapy (anti-CTLA4 and anti-PD1) is seen in 29% of patients overall and grade 3–4 toxicity in 14% of patients.Stauffer’s syndrome is a rare para-neoplastic phenomenon associated with RCC and characterized by abnormal liver function tests, hepato-splenomegaly and histological changes consistent with non-specific hepatitis. We describe a case of RCC treated with anti-CTLA4 and anti-PD1 therapy resulting in immediate liver toxicity and death after 2 months of progressive hepatic impairment. We hypothesize that high IL-6 levels due to Stauffer’s syndrome might have contributed to immune-related hepatic failure.

Item Type: Article
Uncontrolled Keywords: Hepatitis, hepatic failure, immunotherapy, renal carcinoma
Subjects: 600 Tecnologia - Scienze applicate
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici)
600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Marina Spanti
Date Deposited: 25 Jan 2022 15:35
Last Modified: 25 Jan 2022 15:35
URI: http://eprints.bice.rm.cnr.it/id/eprint/21262

Actions (login required)

View Item View Item